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phate. Recently, evidence has emerged that CERK has a role in inﬂammatory signaling of immune
cells. Since obesity is accompanied by chronic, low-grade inﬂammation, we examined whether CERK
might be involved using CERK-null mice. We determined that CERK deﬁciency suppresses diet-
induced increases in body weight, and improves glucose intolerance. Furthermore, we demon-
strated that CERK deﬁciency attenuates MCP-1/CCR2 signaling in macrophages inﬁltrating the
adipose tissue, resulting in the suppression of inﬂammation in adipocytes, which might otherwise
lead to obesity and diabetes.
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The enzyme ceramide kinase (CERK) catalyzes the conversion of
ceramide to ceramide 1-phosphate (C1P). In 2002, the CERK gene
was cloned [1]. This breakthrough stimulatedmany groups to study
CERK and C1P, leading to discoveries in mast cell activation, eicos-
anoid signaling, and anti-apoptotic signaling [2]. Studies also deter-
mined that CERK is involved in cellular inﬂammatory signaling [3].
Obesity, which has grown to epidemic proportions throughout
the world, is an important risk factor for the development of diabe-
tes and cardiovascular disease [4]. Chronic and low-grade inﬂam-
mation is associated with the initial steps of obesity; occurring in
the absence of any infection of microorganisms it is termed ‘‘sterile
inﬂammation’’ [5]. In this study, we investigated CERK involve-
ment in sterile inﬂammation and obesity, which is associated with
diabetes.chemical Societies. Published by E
nase; C1P, ceramide 1-phos-
CCR2, C-C motif chemokine
rrow derived macrophage
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S. Mitsutake).2. Materials and methods
2.1. Animal studies
Generation of CERK-/- mice was previously described [6]. For
diet-induced obesity (DIO), the CERK-/- mice and wild type mice
(C57BL/6J) were fed a high fat diet (60% kcal from fat; 58Y1, Test-
Diet, Richmond, IN) from 4 to 15 weeks of age, and body weights
were measured weekly. Glucose tolerance tests (GTT) were per-
formed as described previously [7].
2.2. Immunohistochemical studies
For histological studies, mice epididymal adipose tissues were
ﬁxed with 4% paraformaldehyde, and 8-lm-thick frozen sections
were prepared as described previously [6]. The sections were
stained with hematoxylin and eosin. For immunohistochemistry,
fats were ﬁrst removed from the sections using a combination of
ethanol and xylene. Endogenous peroxidase was quenched with
3% H2O2, and anti F4/80 antibody (eBioscience) and anti-rat IgG-
horse radish peroxidase (GE Healthcare) were used to stain macro-
phages by Vectastain Elite ABC peroxidase kit (Vector laboratories)
according to manufacture’s instructions. Images were obtained
using a Axioskop 2 plus microscope (Carl Zeiss), and adipocyte celllsevier B.V. All rights reserved.
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4 (Carl Zeiss).
2.3. Real-time PCR
Total RNA was extracted from mice epididymal adipose tissues
using a combination of TRIsol and PureLinkTM RNAMini kits (Invit-
rogen), according to instructions. After ﬁrst strand cDNA synthesis,
real-time PCR was performed as described previously [7]. The tran-
script levels were normalizedwith hypoxanthine guanine phospho-
ribosyl transferase (HPRT). Primer sets used in this study were as
follows:perilipin, sense50-GATGAGAGCCATGACGACCAGAandanti-
sense 50-TGTGTACCACACCACCCAGGA; F4/80, sense 50-TCTGTTCAC-
CATCATCAATGTCC and antisense 50-GACACTTCAGTGCTTTCACTTT-
CAA; IL6, sense 50-CCACTTCACAAGTCGGAGGCTTA and antisense
50-GCAAGTGCATCATCGTTGTTCATAC; TNFa, sense 50- AAGCCTG-
TAGCCCACGTCGTA and antisense 50-GGCACCACTAGTTGGTTGTCT-
TTG; MCP1, sense 50- GCATCCACGTGTTGGCTCA and antisense 50-
CTCCAGCCTACTCATTGGGATCA; Hprt1, sense 50-TTGTTGTTGGATA-
TGCCCTTGACTA and antisense 50-AGGCAGATGGCCACAGGACTA;
adiponectin, sense 50-GTCAGTGGATCTGACGACACCAA and anti-
sense 50-ATGCCTGCCATCCAACCTG; GLUT4, sense 50-CTGTAACTT-
CATTGTCGGCATGG and antisense 50-AGGCAGCTGAGATCTGGTCA-
AAC; IR, sense 50-CAGCTCGAAACTGCATGGTTG and antisense 50-
GGTGACATCCACCTCACAGGAA.
2.4. Preparation of bone marrow-derived macrophages (BMDM)
Samples of bone marrow from the femurs of 6-week old CERK-/-
and WT male mice were placed in RPMI 1640 medium (Sigma)
containing 10% fetal bovine serum (FBS), penicillin/streptomycin,
and recombinant mouse macrophage colony stimulating factor
(M-CSF, 100 ng/ml, Wako Pure Chemicals) as described elsewhere
[8]. Cells were maintained in culture at 1  106 cells/ml for 5 days.
Prior to experiments, BMDM purity was monitored by ﬂow cytom-
etry using an FITC-labeled antibody for the macrophage-speciﬁc
marker F4/80 (BD Bioscience, CA).
2.5. Phagocytosis, adhesion, and cell-migration assay of BMDM
For phagocytosis assays, Texas Red-conjugated zymosan A bio-
particles (Invitrogen) were opsonized with human serum as de-
scribed elsewhere [9]. BMDM were seeded on 60 mm dishes and
cultured for 5 days. After a 15 min incubation of the cells with
the opsonized zymosan particles at 37 C, particles incorporated
into the cells were counted using a confocal laser scanning micro-
scope (LSM510, Carl Zeiss). For cell adhesion assays, 96 well plates
were coated overnight at 4 C with 10 lg/ml ﬁbronectin (Sigma) or
5 lg/ml laminin (Sigma). Wells were washed with phosphate buf-
fered saline (PBS), and 1  105 BMDM were seeded into each well.
After 5 days, the amount of cellular adhesion was monitored using
a Cell Counting Kit-8 (Dojindo, Kumamoto, Japan). Cell migration
assays were performed using Transwell Boyden Chambers (pore
size 8.0 lm, Costar). The lower side of each chamber was precoated
with ﬁbronectin (10 lg/ml) overnight at 4 C, washed with PBS,
and air-dried. Serum-starved cells (1  105 cells) were added to
chamber, and the chambers were placed in 24-well dishes contain-
ing medium with 50 ng/ml MCP-1 or 10% fetal bovine serum (FBS)
and incubated for 3-h at 37 C. Migrated cells were visualized by
staining with Crystal Violet (0.1% in 0.1 M borate (pH 9.0), and
2% ethanol) then counted.
2.6. SDS–PAGE and Western blotting
SDS–PAGE and Western blotting were performed according to
standard methods described previously [7], using anti-CCR2 mouseIgG (Santa Cruz Biotechnology), anti-ERK (p42/44) MAP kinase rab-
bit IgG (Cell Signaling Technology), or anti-phosphorylated ERK
(pERK) mouse IgG (Santa Cruz Biotechnology) as the primary anti-
body, and an anti-mouse IgG-HRP antibody (GE Healthcare), or
anti-rabbit IgG-HRP antibody (GE Healthcare) as the secondary
antibody. Bands were detected using a combination of an ECL plus
kit (GE Healthcare) and X-ray ﬁlm exposure.3. Results
3.1. CERK deﬁciency suppresses diet-induced increases in body weight,
and improves glucose intolerance
We previously reported that ceramide kinase (CERK) might act
as a modulator for chronic activation of mast cells [10], and others
have indicated that ceramide 1-phosphate (C1P), is a mediator of
eicosanoid synthesis [11]. Thus, there is emerging evidence that
CERK is involved in cellular inﬂammatory processes [2]. A recent
study suggested that obesity is accompanied by a state of chronic,
low-grade inﬂammation that contributes to insulin resistance and
type 2 diabetes [5]. We investigated a possible relationship be-
tween obesity and CERK using the diet-induced obesity (DIO) ani-
mal model. CERK-/- and wild type (WT) mice were fed a high-fat
diet from 4 to 15 weeks of age. In this obesity model, 14–20 weeks
of diet are sufﬁcient to cause obesity and insulin-resistance [7]. As
expected, the body weights of the WT mice were signiﬁcantly in-
creased (Fig. 1A). Interestingly, though, CERK deﬁciency strongly
prevented the increase in body weight. We also examined the ef-
fect of CERK deﬁciency on glucose intolerance or insulin resistance
(Fig. 1B). Glucose tolerance tests (GTT) reﬂected impaired blood
glucose clearance in WT mice, as evidenced by a decreased ability
to lower their blood glucose. However, the CERK-/- mice showed
signiﬁcantly lower glucose levels than in the WT animals, indicat-
ing that CERK deﬁciency increases insulin sensitivity.
3.2. CERK deﬁciency improves adipose function
Smaller adipocytes are usually observed with increased insulin
sensitivity [12]. To examine the adipocytes of the test animals, we
prepared sections of epididymal adipose and stained them with
hematoxylin and eosin (Fig. 1C). We also measured the surface area
of each adipocyte (Fig. 1D), and plotted its distribution (Fig. 1E).
The results clearly indicate that the CERK-/- mice had a greater
number of small adipocytes than did the WT mice.
To gain insight into the mechanisms behind the effects of CERK
deﬁciency on diet-induced obesity and insulin resistance, we
examined the expression levels of genes for proteins associated
with obesity, using real-time quantitative PCR. For example, perili-
pin, a coat protein of lipid droplets in adipocytes, is abundant in
small adipocytes [13]. The adipose tissue of CERK-/- mice ex-
pressed perilipin at levels higher than those observed in WT mice
(Fig. 2A). Recent investigations suggest that obesity is associated
with a state of chronic, low-grade inﬂammation in adipose tissue,
which is known to produce inﬂammatory cytokines and chemo-
kines [5]. Adipose tissue from WT mice expressed high levels of
the inﬂammatory cytokines, IL-6 and TNFa, which have been
implicated as playing a role in obesity. However, CERK deﬁciency
strongly suppressed the elevation of these inﬂammatory cytokines
(Fig. 2B, C). Additionally, we examined the expression levels of
insulin receptor (IR), GLUT4 (major glucose transporter in adipose
tissue), and adiponectin to discuss insulin-signaling of adipose tis-
sue in these mice (Fig. 2F–H), and showed that CERK-deﬁciency
improved HFD-induced decrease of IR, GLUT4, and adiponectin.
These results indicated that the adipocytes of CERK-/- mice main-
tained normal insulin-signaling even after HFD-feeding.
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Fig. 1. Effects of CERK deﬁciency on diet-induced body weight gain and adipose tissue. Wild type (WT) and CERK-/- mice were fed a high-fat diet as described in Section 2. (A)
Body weights increased signiﬁcantly in the wild type (WT) mice but not in the CERK-/- mice. (B) Glucose tolerance tests (GTT) were performed on the mice in (A). (A–B) n = 13
and 10 for WT and CERK-/-, respectively. ⁄, P < 0.001. (C) Hematoxylin and eosin staining indicates a greater number of small adipocytes in CERK-/- adipose tissues than in WT
tissues. Image scale is 100 lm. (D and E) Cell surface areas of adipose tissues fromWT and CERK-/- mice were measured, and the means (D) and distributions (E) were plotted.
The data include 1235 cells from WT (ﬁve mice) and 1279 cells from CERK-/- mice (ﬁve mice). #, P < 0.000001.
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tissue
The inﬂammatory processes associated with obesity have not
been fully established, though there is much interest in the role
of adipose tissue macrophages in the inﬂammation characteristi-
cally observed in obesity [14]. Monocyte chemoattractant pro-
tein-1 (MCP-1) is known to induce macrophage inﬁltration into
adipose tissue. Adipose tissue from CERK-/- mice expressed lower
levels of MCP-1 than did tissue from WT mice (Fig. 2D). Addition-
ally, the expression levels of a macrophage-speciﬁc gene, F4/80, in
CERK-/- mice were nearly half those in WT mice, indicating that
MCP-1-induced inﬁltration of macrophages into adipose is strongly
inhibited by CERK deﬁciency.
A recent study revealed that macrophages recruited to adipose
are localized around dead adipocytes, forming ‘‘crown like
structures (CLS)’’ that produce additional chemokines (including
MCP-1) and cytokines, resulting in worsening of inﬂammation
and subsequent insulin resistance [15]. In the adipose of the WT
mice, there were many adipocytes surrounded by macrophages
forming CLS (Fig. 3A; arrow). The CLS-surrounded adipocytes
reached nearly 20 percent of the total adipocytes counted
(Fig. 3B). Surprisingly, there were almost no CLS in the adipose of
CERK-/- mice (Fig. 4A, B).
3.4. CERK regulates MCP-1/CCR2 signaling in macrophages
We previously described that CERK is involved in the differenti-
ation of leucocytes [16], and that it acts as a Ca2+ sensor of degran-
ulation in mast cells [17]. With this in mind, we next examinedwhether CERK is involved in macrophage function using CERK-/-
mouse bone marrow-derived macrophages (BMDM). BMDM were
isolated and cultured as described in Section 2. After 5 days in
culture, all progenitor cells had completely differentiated to F4/
80-positive macrophages, indicating that macrophage differentia-
tion is not impaired in the BMDM from CERK-/- (Fig. 4A). We next
compared the phagocytosis (Fig. 4B), adhesion to extracellular
matrix (Fig. 4C), and cell migration (Fig. 4D) of BMDM from WT
and CERK-/- mice. Phagocytosis of zymosan particles (Fig. 4A) and
adhesion of the cells to ﬁbronectin and laminin did not differ
between the BMDM from WT and CERK-/- mice.
MCP-1-induced cell migration was signiﬁcantly reduced in
BMDM from CERK-/- mice, but no such reduction was observed
in serum-induced cell migration (Fig. 4D). Expression of CCR2, a
receptor for MCP-1, was similar in BMDM from both mice
(Fig. 4E), yet MCP-1-induced phosphorylation of ERK was sup-
pressed in the BMDM from CERK-/- mice. Addition of short-chain
C8-C1P has been demonstrated to induce phosphorylation of ERK
in macrophages [18], therefore CERK/C1P might generally have
important functions in ERK-signaling in macrophages. Altogether,
these results suggest that CERK deﬁciency attenuates MCP-1/
CCR2 signaling in macrophages inﬁltrating adipose tissue, resulting
in the suppression of inﬂammation in adipose, which otherwise
leads to obesity and diabetes (Fig. 5).4. Discussion
An increase in adiposity is suggested to cause a low grade
chronic inﬂammation, leading to the activation of various immune
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S. Mitsutake et al. / FEBS Letters 586 (2012) 1300–1305 1303cells, and ﬁnally resulting in severe obesity and diabetes [4]. In this
process, the inﬁltration of macrophages into adipose tissue is
thought to be a crucial event, in which MCP-1 and its receptor
CCR2 are key players [15]. Indeed, mice with targeted deletions
in the genes for MCP-1 or its receptor CCR2 have dramaticallydecreased numbers of macrophages or CLS in adipose tissue,
decreased inﬂammation in fat, and protection from high-fat diet-
induced insulin resistance [19]. Thus, the inhibition of macrophage
inﬁltration of adipose tissue is considered a potent therapeutic
strategy for diabetes associated with obesity. In the study pre-
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1304 S. Mitsutake et al. / FEBS Letters 586 (2012) 1300–1305sented here, we demonstrated that CERK deﬁciency attenuates
MCP-1/CCR2 signaling in macrophages inﬁltrating adipose tissue,
resulting in the prevention of obesity and diabetes. Dr. Claro’s
group reported that ceramide kinase govern the biogenesis of lipid
droplets [20], and we also found that CERK-/- mice have a greater
number of small adipocytes than the WT mice do, indicating CERK
is involved in the swelling process of adipocytes. Thus, not only the
MCP1/CCR2-signaling in macrophages, but also the swellingprocess of adipocytes would be impaired in CERK-/- mice. Our ﬁnd-
ings might provide new insight into the development of pharma-
ceuticals against obesity and diabetes.
The number of published studies regarding sphingolipids and
diabetes, and obesity is steadily increasing. For example, in obese
ob/ob mice diminishing glycosphingolipid biosynthesis using
AMP-DNM, an inhibitor of glucosylceramide synthase, reduced
the number of adipose tissue macrophages and CLS and restored
S. Mitsutake et al. / FEBS Letters 586 (2012) 1300–1305 1305insulin signaling [21]. A study in our lab revealed that sphingomy-
elin synthase 2 is involved in diet-induced obesity [7]. Now, sphin-
golipid metabolites, such as ceramide, C1P, and sphingosine, have
been implicated in inﬂammatory responses in various sites of
action [22]. Enzymes involved in ceramide-pathways might have
potential as targets for drug discovery against diabetes.
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